-
SAB Biotherapeutics Launches Utah-Based Subsidiary SAB Capra, LLC.
Published: Dec 22, 2017 Transgenic goats broaden application of premier immunotherapy platformwith personalized medicine, testing and diagnostics Sioux…
-
SAB Biotherapeutics’ Pharm Groundbreaking Highlights Broad Impact
Published: Oct 06, 2017 SAB Biotherapeutics expands operations with first-of-its-kind greenfield biopharmaceutical pharm under construction Sioux Falls,…
-
SAB Biotherapeutics Integrates Operations With New Production Facility
First-of-its kind greenfield biological pharm under construction August 30, 2017 11:15 AM Eastern Daylight Time SIOUX FALLS, S.D.(BUSINESS WIRE)SAB…
-
Pharmaceutical Entrepreneur, William J. Polvino, M.D. Joins SAB Biotherapeutics’ Business Advisory Board
August 03, 2017 02:04 PM Eastern Daylight Time SIOUX FALLS, S.D.(BUSINESS WIRE)SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical…
-
SAB Biotherapeutics Strengthens Board Of Directors With Appointment Of Biotech Veteran
April 26, 2017 12:00 PM Eastern Daylight Time SIOUX FALLS, S.D.(BUSINESS WIRE)SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical…
-
SAB Biotherapeutics Names Christoph Bausch As Chief Science Officer
April 25, 2017 01:34 PM Eastern Daylight Time SIOUX FALLS, S.D.(BUSINESS WIRE)SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical…
-
SAB Biotherapeutics’ Immunotherapy Proposal Among Top Platform Technology Solutions In Recent WHO Report
September 20, 2016 10:07 AM Eastern Daylight Time BETHESDA, Md. & SIOUX FALLS, S.D.(BUSINESS WIRE)SAB Biotherapeutics (SAB), a clinical-stage…
-
SAB Biotherapeutics Receives $1.42 Million SBIR Grant To Advance Influenza Treatment
September 07, 2016 09:13 AM Eastern Daylight Time SIOUX FALLS, S.D.(BUSINESS WIRE)SAB Biotherapeutics, a clinical-stage biopharmaceutical development…
-
SAB Biotherapeutics Announces Contract With BARDA To Advance First MERS Treatment
August 24, 2016 09:16 AM Eastern Daylight Time SIOUX FALLS, S.D.(BUSINESS WIRE)SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical…
-
Phase I Clinical Trials Underway For First MERS Treatment
August 11, 2016 07:00 AM Eastern Daylight Time SIOUX FALLS, S.D.(BUSINESS WIRE)SAB Biotherapeutics, Inc. (SAB), a leading biopharmaceutical…
-
New Study By University Of Maryland School Of Medicine Researchers Finds Promising Results For Treatment
Approach uses genetically modified cows to manufacture MERS-fighting antibodies Baltimore, Md., February 17, 2016 - In a new study, University of…
-
SAB Biotherapeutics Produces New Human Antibody Treatment For MERS-CoV
DiversitAb™ platform provides rapid response to emerging infectious diseases February 17, 2016 02:00 PM Eastern Standard Time SIOUX FALLS,…